China Biologic Products, Inc. (CBPO): Min Fang , director of China Biologic Products, Inc. sold 2,775,000 shares on Jun 8, 2016. The Insider selling transaction was reported by the company on Jun 8, 2016 to the Securities and Exchange Commission. The shares were sold at $111.00 per share for a total value of $308024992 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 23, 2016, Gang Cbpo Yang (Corporate Vice President) sold 26,563 shares at $113.61 per share price.On May 23, 2016, Ming Yin (Senior Corporate VP) sold 19,618 shares at $113.61 per share price.Also, On May 23, 2016, Ming Yang (Chief Financial Officer) sold 13,908 shares at $113.61 per share price.On Mar 15, 2016, Zhijing Cbpo Liu (Corporate Vice President) sold 282 shares at $108.00 per share price.
Shares of China Biologic Products Inc (CBPO) ended Tuesday, Jun 7, 2016 session in red amid volatile trading. The shares closed down -2.6 points or -2.17% at $117.04 with 4,02,346 shares getting traded. Post opening the session at $119.66, the shares hit an intraday low of $116.24 and an intraday high of $119.72 and the price vacillated in this range throughout the day. The company has a market cap of $3,112 M and the number of outstanding shares has been calculated to be 2,65,90,974 shares. The 52-week high of China Biologic Products Inc is $144.2899 and the 52-week low is $80.6.
China Biologic Products Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research development manufacturing and sales of human plasma-based biopharmaceutical products in China. China Biologic has a product portfolio with over 20 different dosage forms of plasma products. The Company’s principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through two subsidiaries namely Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co. Ltd. The Company also holds an interest in Xi’an Huitian Blood Products Co. Ltd. a plasma products company. Its products include human albumin human immunoglobulin IVIG thymopolypeptides injection human hepatitis B immunoglobulin human rabies immunoglobulin human tetanus immunoglobulin placenta polypeptide Factor VIII and human prothrombin complex concentrate (PCC).